Critics slam FDA's latest DMD drug approval, forces company to pause drug launchShared by:
This week, the US saw the first steroid for DMD being FDA-approved. However, the drug was slated for an inflated price of USD89,000 a year. After Congress and frustrated parents questioned the price hike, the company has paused the drug launch.
14 Feb 2017 - General